The National Capital Consortium for Pediatric Device Innovation recently announced five electrophysiology devices that could monitor and treat congenital heart disease and arrhythmia in pediatric patients.
The five winners of the annual NCC-PDI “Make Your Medical Device Pitch for Kids!” competition will share a $150,000 grant funding from the FDA to support the advancement of pediatric medical devices.
The competition was conducted by NCC-PDI partner Medtech Innovator and was part of the 9th annual Symposium on Pediatric Device Innovation.
Congenital heart defects are the most common type of birth defect, according to the Centers for Disease Control and Prevention. It affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias. There has been a lot of advances in technologies to care for adult arrhythmias within the last 10 years, but pediatrics is slower to innovate with only five devices approved for use in children in the same timespan. As a result, pediatric patients are often treated with off-label or improvised devices to treat pediatric arrhythmias.
“Recognizing this unmet need, NCC-PDI opened the challenge earlier this year to select companies to enter Medtech Innovator’s pediatric accelerator program, made possible by NCC-PDI. The five companies have immensely benefited from the accelerator program and are well-positioned to compete for funding. They have the potential to advance pediatric health and provide a greater standard of care for children living with CHD,” Kolaleh Eskandanian, VP and chief innovation officer at Children’s National Hospital and principal investigator of NCC-PDI, said in a news release.
“For too long, the unique needs of children have been overlooked in pediatric device development. Thanks to the support of the FDA, we are able to build our challenge competitions around the direst unmet needs, which are determined through a thorough needs assessment and market analysis conducted to inform each request for proposal. The funding incentivizes pediatric innovation and helps more companies navigate the path to commercialization,” Eskandanian said.
The NCC-PDI competition is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Hospital and the A. James Clark School of Engineering at the University of Maryland, with support from partners Medtech Innovator, BioHealth Innovation and design firm Archimedic. All competitors had an opportunity to participate in a year-long accelerator program from Medtech Innovator.
“It has been a privilege getting to know and support the dedicated teams pioneering these transformative health solutions during Medtech Innovator’s accelerator program, which provides individualized mentorship and resources that companies need to successfully advance toward product commercialization,” Medtech Innovator CEO Paul Grand said. “Pediatric devices are extremely challenging to bring to market, and we’re honored to leverage the world’s leading device ecosystem to ensure that these life-improving innovations successfully reach the children who so desperately need them.”